ChemoMetec A/S specializes in high-precision cell counting and analysis instruments used across the life sciences sector. The company operates through four main segments: Instruments, Consumer Goods, Service, and Others. Its core offerings include the NucleoCounter series of automated cell counters, alongside associated consumables such as disposable cartridges, analysis chambers, and reagents. ChemoMetec's technology is widely utilized in drug development, bioprocessing, and the rapidly growing cell and gene therapy markets. Headquartered in Allerød, Denmark, the company maintains a global footprint with a direct sales and support network serving leading pharmaceutical and biotechnology companies worldwide. Its business model relies on a "razor and blade" strategy, generating recurring revenue from the continuous sale of specialized consumables to its installed instrument base.
